Yaping [29] found that VEGFA was highly upregulated in the T2D retina; it is a new potential therapeutic target and biomarker for proliferative diabetic retinopathy treatment and diagnosis [30]. This evidence concerns the gene VEGFA and type 2 diabetes mellitus.